Venmax Drugs: Trading Window Closes for Q2 FY27 Results

Venmax Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut for all insiders, including designated persons and their immediate relatives, effective from October 1, 2026. This restriction begins forty-eight hours after the declaration of the company's unaudited financial results for the quarter ended September 30, 2026. The specific date for the Board Meeting to consider these results will be communicated later.